Related Experiment Video

Updated: Mar 28, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

20.8K

MicroRNA Regulation of Human Breast Cancer Stem Cells

Yohei Shimono1,2, Junko Mukohyama3, Shun-Ichi Nakamura4,5

  • 1Division of Molecular and Cellular Biology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan. yshimono@med.kobe-u.ac.jp.

Journal of Clinical Medicine
|December 30, 2015
PubMed

Insights

MicroRNAs (miRNAs) are key regulators in breast cancer stem cells (CSCs). Dysregulated miRNAs impact stem cell maintenance, differentiation, and disease progression, offering potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Stem Cell Biology

Background:

  • MicroRNAs (miRNAs) regulate fundamental biological processes, including stem cell functions.
  • miRNA dysregulation is implicated in various human diseases, notably cancer.
  • Breast cancer stem cells (CSCs) play a critical role in tumor initiation and progression.

Purpose of the Study:

  • To identify and describe miRNAs differentially expressed in human breast CSCs.
  • To explore the role of these miRNAs in regulating CSC maintenance and related pathways.
  • To understand miRNA involvement in the distinct phenotype of metastatic breast CSCs.

Main Methods:

  • Comparative analysis of miRNA expression profiles between human breast CSCs and non-tumorigenic cancer cells.
  • Examination of miRNA expression patterns in normal mammary stem/progenitor cells.
  • Review of literature on specific miRNA clusters (e.g., miR-200, miR-183) and their targets in CSCs.

Main Results:

  • A set of miRNAs were identified as differentially expressed in human breast CSCs compared to non-tumorigenic cells.
  • These miRNAs, including miR-200, miR-183, and let-7 families, target key stem cell maintenance genes and pathways (BMI1, Wnt, Notch).
  • Metastatic breast CSCs exhibit distinct phenotypes potentially influenced by specific miRNA regulations.

Conclusions:

  • miRNAs are crucial regulators of human breast CSC maintenance, self-renewal, and epithelial-to-mesenchymal transition.
  • Understanding miRNA dysregulation in breast CSCs is vital for advancing cancer research and developing targeted therapies.
  • Further investigation into miRNA regulation of metastatic CSCs will enhance comprehension of tumor progression.
Keywords:
Bmi1Wnt signalingcancer stem cellsepithelial-to-mesenchymal transition (EMT)metastasismicroRNA

More Related Videos

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples07:03

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Published on: October 2, 2020

5.2K
Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization06:01

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

Published on: June 7, 2016

7.2K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.3K